5′‐Nucleotide phosphodiesterase isozyme‐V in health, in cancer, and in viral hepatitis

10Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An abnormal, fast‐moving 5′‐nucleotide phosphodiesterase isozyme was found in 90.0% of 20 Malaysian patients with primary hepatoma and in 23.5% of 391 Malaysian patients with various malignant diseases; it was also discovered in 42.9% of 14 Malaysian and American patients with clinically active hepatitis B infection; in 16.7% of 18 healthy American blood bank donors who were positive for hepatitis B surface antigen (HBsAg); in 13.9% of 287 healthy Malaysian blood bank donors, some positive for HBsAg; and in none of 160 healthy American donors who were negative for HBsAg. A correlation of this abnormal isozyme with hepatoma and with infectious hepatitis B is clearly evident. Cancer 45:795‐798, 1980. Copyright © 1980 American Cancer Society

Cite

CITATION STYLE

APA

Lei‐Injo, L. E., Tsou, K. C., Lo, K. W., Lopez, C. G., Balasegaram, M., & Ganesan, S. (1980). 5′‐Nucleotide phosphodiesterase isozyme‐V in health, in cancer, and in viral hepatitis. Cancer, 45(4), 795–798. https://doi.org/10.1002/1097-0142(19800215)45:4<795::AID-CNCR2820450431>3.0.CO;2-L

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free